Reducing Treatment Burden in IBD with At-Home Therapy Options

Opinion
Video

Jean-Frederic Colombel, MD, offers insights into subcutaneous infliximab-dyyb injection, detailing its administration and approved indications for ulcerative colitis and Crohn's disease.

  1. The FDA has now approved a subcutaneous infliximab injection for IBD. Can you provide an overview of subcutaneous infliximab-dyyb injection? What is the significance of this approval?
    1. How could this impact patients with UC and CD?
  2. What are the indications for subcutaneous infliximab-dyyb injection?
    1. When and how can this therapy be started?
Recent Videos
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
Reagan Udall Foundation’s PTSD Meeting Was “Reassuring,” says Healthcare Expert
Jonathan Barratt, MD | Credit: IgA Nephropathy Foundation
© 2024 MJH Life Sciences

All rights reserved.